The VeraCept Intrauterine Contraceptive is currently in a clinical study in the United States. It is limited by United States Federal Law to Investigational Use.
VeraCept is a hormone-free, low-dose copper releasing intrauterine device intended to prevent pregnancy. VeraCept is undergoing Phase 3 Clinical Trials in the United States.
The VeraCept Difference
Properties of VeraCept currently being investigated in the clinical study include:
- Lower copper dosage
- Smaller insertion profile
- Pre-loaded Introducer
- Pre-trimmed retrieval thread
- Flexible shape memory frame
Learn More About VeraCept
CAUTION: Limited by Federal Law to Investigational Use.